Nestlé has today announced its latest science-based innovation for early-life nutrition. The company has developed Sinergity, a proprietary blend that combines a specific probiotic with six human milk oligosaccharides (HMOs) to support age-adapted infant development by unlocking specific health benefits.
Probiotics play a key role in supporting the gut microbiome and immunity during infant development. Similarly, HMOs, a crucial component of breastmilk, support intestinal microbiota development and nurture the immune system during early life.
Over the years, Nestlé has been at the forefront of understanding the composition of various nutrients and bioactives that are present in breastmilk such as proteins and HMOs. Nestlé also has extensive expertise in probiotics and their role in nutrition and health.
|